Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial-Reference-Cited by-同舟云学术

Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial

Published:2002-03 Issue:3 Volume:68 Page:144-149
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Avilés Agustin,Delgado Serafin,Fernández Raúl,Talavera Alejandra,Neri Natividad,Huerta-Guzmán Judith

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-0609.2002.01542.x/fullpdf

Reference22 articles.

1. Is radiotherapy curative for stage I and stage II low grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University;McManus;J Clin Oncol,1996

2. What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma;McManus;Int J Radiat Oncol Biol Phys,1998

3. The low grade lymphomas;Mendenhall;Semin Radiat Oncol,1995

4. The effect of intensive intermittent maintenance therapy in advanced low-grade non-Hodgkin's lymphoma;Ezdinli;Cancer,1987

5. Long-term follow-up of patients with low-grade malignant lymphoma treated with doxorubicin base chemotherapy or chemoimmunotherapy;Dana;J Clin Oncol,1993

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Primary Causes of Death in Patients with Non-Hodgkin’s Lymphoma: A Retrospective Cohort Study

;Cancer Management and Research;2020-05

2. Cardiovascular mortality trends in non-Hodgkin’s lymphoma: a population-based cohort study;Expert Review of Anticancer Therapy;2017-12-15

3. Non-Hodgkin Lymphomas: Impact of Rituximab on Overall Survival of Patients with Diffuse Large B-Cell and Follicular Lymphoma;Archives of Medical Research;2015-08

4. Tumoren des lymphatischen Systems;Strahlentherapie;2013

5. External Beam Radiotherapy Followed by 90Y Ibritumomab Tiuxetan in Relapsed or Refractory Bulky Follicular Lymphoma;International Journal of Radiation Oncology*Biology*Physics;2011-03